rs761907604
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001283009.2(RTEL1):c.3063C>A(p.His1021Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,612,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.3063C>A | p.His1021Gln | missense_variant | 31/35 | ENST00000360203.11 | NP_001269938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.3063C>A | p.His1021Gln | missense_variant | 31/35 | 5 | NM_001283009.2 | ENSP00000353332.5 | ||
RTEL1 | ENST00000508582.7 | c.3135C>A | p.His1045Gln | missense_variant | 31/35 | 2 | ENSP00000424307.2 | |||
RTEL1 | ENST00000370018.7 | c.3063C>A | p.His1021Gln | missense_variant | 31/35 | 1 | ENSP00000359035.3 | |||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.*665C>A | non_coding_transcript_exon_variant | 28/35 | 5 | ENSP00000457428.1 | ||||
RTEL1-TNFRSF6B | ENST00000492259.6 | n.*665C>A | 3_prime_UTR_variant | 28/35 | 5 | ENSP00000457428.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152218Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246840Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134376
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459796Hom.: 0 Cov.: 33 AF XY: 0.00000551 AC XY: 4AN XY: 726056
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152336Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74484
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2020 | The c.3135C>A (p.H1045Q) alteration is located in exon 31 (coding exon 30) of the RTEL1 gene. This alteration results from a C to A substitution at nucleotide position 3135, causing the histidine (H) at amino acid position 1045 to be replaced by a glutamine (Q). The p.H1045Q alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 08, 2022 | - - |
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2022 | This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1021 of the RTEL1 protein (p.His1021Gln). This variant is present in population databases (rs761907604, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RTEL1-related conditions. This variant is also known as c.3135C>A (p.His1045Gln). ClinVar contains an entry for this variant (Variation ID: 566087). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
RTEL1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2024 | The RTEL1 c.3135C>A variant is predicted to result in the amino acid substitution p.His1045Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.044% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at